Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Non-‘classical’ MEKs: A review of MEK3-7 inhibitors

Bioorganic & Medicinal Chemistry Letters(2020)10.1016/j.bmcl.2020.127203Source: DataRank Database

Non-‘classical’ MEKs: A review of MEK3-7 inhibitors is a research paper published in Bioorganic & Medicinal Chemistry Letters (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: bronzeTopics (26)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Karl A. Scheidt ORCID,Ada J. Kwong ORCID

Live enrichment

PubMed:32389527

National Institutes of Health

Grant: 1R01CA188015-01A1

Discovery of Selective MAP2K4 Inhibitors to Target Metastasis

National Institutes of Health

Grant: 1T32GM105538-01

Chemistry of Life Processes Predoctoral Training Program

NCI NIH HHS

Grant: R01 CA188015

NIGMS NIH HHS

Grant: T32 GM105538

bronzeLicense: Elsevier TDM

https://doi.org/10.1016/j.bmcl.2020.127203

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299838

https://pubmed.ncbi.nlm.nih.gov/32389527

https://dx.doi.org/10.1016/j.bmcl.2020.127203

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsCell Line, TumorHumansMitogen-Activated Protein Kinase KinasesPhosphorylationProtein Kinase Inhibitors

MeSH Terms

AnimalsCell Line, TumorHumansMitogen-Activated Protein Kinase KinasesPhosphorylationProtein Kinase Inhibitors

Keywords

Mitogen-Activated Protein Kinase KinasesCell Line, TumorAnimalsHumansPhosphorylationProtein Kinase InhibitorsDrug discoveryKinasesMitogen-activated protein kinasesSmall molecule inhibitorsStructure-activity relationships

Sustainable Development Goals

SDG 3: 3. Good health